The Lungitude Foundation is a registered Australian charity focused on funding and facilitating world-class translational research, advocating for lung transplant excellence, building a strong community of support, and educating key audiences.

Clinical and research endeavours supported by the Lungitude Foundation benefit the lives of people who need or receive a lung transplant, on a national and global scale. All research funded by the Lungitude Foundation is translational, 'bench to bedside' health and medical research - which means research undertaken in the lab ('the bench') or in the clinics by the research teams, is translated into treatments or therapies that benefit people at the 'bedside' as soon as possible.

The Lungitude Foundation partners with leading medical and health organisations in the field of lung transplantation. We are a major benefactor of The Alfred Hospital Lung Transplant Research Team which is a world leader in optimising patient outcomes following lung transplantation.

The Alfred is the Nationally Funded Centre for all Australian paediatric lung transplantations. The youngest two patients have both been 5 years of age at the time of transplantation.

The Alfred's patient outcomes following lung transplantation remain the world's best with 96% 1-year and 74% 5-year survival rates; figures that are significantly better than those reported by the International Society for Heart and Lung Transplantation Registry.

Our focus on promoting clinical and research excellence has very realistic prospects of improving the health of all transplant patients, not just lung transplant recipients.

We invite you to help support this worthy cause.